EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Stepwise identification of an SQSTM1::NTRK3 fusion in papillary thyroid carcinoma: Diagnostic pitfalls and the value of integrative genomic profiling

Yoichiro Okubo, Mei Kadoya, Soji Toda, Ryuji Nasu, Shu Yuguchi, Kota Washimi, Shinya Sato, Yukihiko Hiroshima, Hiroyuki Hayashi, Katsuhiko Masudo, Yohei Miyagi

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.156100 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Yoichiro Okubo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. Electronic address: yoichiro0207@hotmail…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Cancer, Papillary, Sequestosome-1 Protein, Receptor, trkC. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kanagawa Prefectural Hospital Organisation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 70-year-old woman presented with bilateral cervical lymphadenopathy and multiple pulmonary nodules. She had undergone right thyroid lobectomy in childhood. Ultrasonography revealed a newly identified mass in the remnant left thyroid lobe and enlarged cervical lymph nodes. An excisional biopsy of the cervical lymph nodes diagnosed metastatic papillary thyroid carcinoma (PTC) with trabecular and solid architecture, pale cytoplasm, and nuclear grooves. Immunohistochemistry for BRAF V600E was negative, while pan-TRK showed cytoplasmic staining. Initial molecular testing using the Oncomine Dx Target Test Multi-CDx System failed to detect alterations in BRAF, RET, or NTRK. However, due to strong histological suspicion and TRK immunoreactivity, comprehensive genomic profiling (CGP) involving both DNA and RNA analysis subsequently revealed an SQSTM1::NTRK3 fusion. This case underscores the importance of integrating histopathology, immunohistochemistry, and RNA-based CGP to identify rare but actionable gene fusions. Moreover, long-term preservation of formalin-fixed paraffin-embedded (FFPE) tissue enabled retrospective genomic testing, particularly when initial panel testing was inconclusive or delayed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid Cancer, PapillarySequestosome-1 ProteinReceptor, trkCBiomarkers, TumorHumansFemaleAgedGene Fusion

Stichwörter der Autor:innen

Comprehensive genomic profilingFFPE tissue preservationPan-TRK immunohistochemistryPapillary thyroid carcinomaSQSTM1::NTRK3 fusion

Substanzen

Sequestosome-1 ProteinReceptor, trkCSQSTM1 protein, humanNTRK3 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. Electronic address: yoichiro0207@hotmail.com.
  • Department of Endocrine Surgery, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
  • Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.
  • Department of Pathology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, 2-3-2, Nakao, Asahi-ku,…
  • Department of Cancer Genome Medicine, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan; Advanced Cancer Therapeutics Division, Kanagawa Cancer Center Research Institute, 2-3-2, Nakao, A…
  • Department of Pathology, Yokohama Municipal Citizen's Hospital, 1-1 Mitsuzawanishimachi, Kanagawa-ku, Yokohama, Kanagawa 221-0855, Japan.

Förderung

  • Kanagawa Prefectural Hospital Organisation
  • Japan Society for the Promotion of Science

Zitieren

APA

Okubo, Y., Kadoya, M., Toda, S., Nasu, R., Yuguchi, S., Washimi, K., Sato, S., Hiroshima, Y., Hayashi, H., Masudo, K., & Miyagi, Y. (2025). Stepwise identification of an SQSTM1::NTRK3 fusion in papillary thyroid carcinoma: Diagnostic pitfalls and the value of integrative genomic profiling. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156100

Vancouver

Okubo Y, Kadoya M, Toda S, Nasu R, Yuguchi S, Washimi K, et al. Stepwise identification of an SQSTM1::NTRK3 fusion in papillary thyroid carcinoma: Diagnostic pitfalls and the value of integrative genomic profiling. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156100

BibTeX
@article{Okubo2025,
  author = {Okubo, Yoichiro and Kadoya, Mei and Toda, Soji and Nasu, Ryuji and Yuguchi, Shu and Washimi, Kota and Sato, Shinya and Hiroshima, Yukihiko and Hayashi, Hiroyuki and Masudo, Katsuhiko and Miyagi, Yohei},
  title = {Stepwise identification of an SQSTM1::NTRK3 fusion in papillary thyroid carcinoma: Diagnostic pitfalls and the value of integrative genomic profiling},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.156100}
}
Kostenlos starten →